AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Nabriva Therapeutics plc
$0.00
+$0.00 (+0.00%)
Previous Close
$0.00
Day Range
$0.00 - $0.00
Year Range
$0.00$0.00
Market Cap
323
AVG Volume
485
Trailing/Forward PE
-0/0
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
Other OTC
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: NBRVF
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 13 Nov 2026.
Video analysis: NBRVF
All videosNo video analysis for this stock yet. Request one from our team.
News: NBRVF
Similar companies
-
Brainstorm Cell Therapeutics Inc.
BCLI
·
Other OTC
Compare
-
Creative Medical Technology Holdings, Inc.
CELZ
·
NASDAQ
Compare
-
Evofem Biosciences, Inc.
EVFM
·
Other OTC
Compare
-
G Medical Innovations Holdings Ltd
GMVDF
·
Other OTC
Compare
-
Hepion Pharmaceuticals, Inc.
HEPA
·
Other OTC
Compare
-
Jupiter Neurosciences, Inc.
JUNS
·
NASDAQ
Compare